Next Article in Journal
Pulicaria glutinosa Extract: A Toolbox to Synthesize Highly Reduced Graphene Oxide-Silver Nanocomposites
Next Article in Special Issue
Melatonin Stimulates Dendrite Formation and Complexity in the Hilar Zone of the Rat Hippocampus: Participation of the Ca++/Calmodulin Complex
Previous Article in Journal
Cloud Computing-Based TagSNP Selection Algorithm for Human Genome Data
Previous Article in Special Issue
Melatonin and Female Hormone Secretion in Postmenopausal Overweight Women
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(1), 1111-1130; doi:10.3390/ijms16011111

Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression

1
National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "G. Mazzini", ASL 4, 64100 Teramo, Italy
2
Department of Neuroscience and Imaging, University "G. D'Annunzio", 66013 Chieti, Italy
3
Department of "Scienze della Formazione", University of Catania, 95121 Catania, Italy
4
Sri Sathya Sai Medical Educational and Research Foundation, Medical Sciences Research Study Center, Prasanthi Nilayam, 40-Kovai Thirunagar Coimbatore-641014, 641014 Tamilnadu, India
5
Laboratory of Molecular Psychiatry and Psychopharmacotherapeutics, Section of Psychiatry, Department of Neuroscience, University School of Medicine "Federico II", 80131 Naples, Italy
6
Hermanas Hospitalarias, FoRiPsi, Villa S. Giuseppe Hospital, 63100 Ascoli Piceno, Italy
7
Hermanas Hospitalarias, FoRiPsi, Department of Clinical Neurosciences, Villa San Benedetto Menni, Albese con Cassano, 22032 Como, Italy
8
Department of Psychiatry and Behavioral Sciences, Leonard Miller School of Medicine, University of Miami, Miami, FL 33124, USA
9
Department of Psychiatry and Neuropsychology, University of Maastricht, 6200 MD Maastricht, The Netherlands
10
Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy
11
Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, 00168 Rome, Italy
Deceased.
*
Author to whom correspondence should be addressed.
Academic Editor: Rudiger Hardeland
Received: 31 July 2014 / Accepted: 23 December 2014 / Published: 5 January 2015
(This article belongs to the Special Issue Advances in the Research of Melatonin 2014)
View Full-Text   |   Download PDF [722 KB, uploaded 5 January 2015]

Abstract

Agomelatine, a melatonergic antidepressant with a rapid onset of action, is one of the most recent drugs in the antidepressant category. Agomelatine’s antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 receptors present in the suprachiasmatic nucleus, as well as to its effects on the blockade of 5-HT2c receptors. Blockade of 5-HT2c receptors causes release of both noradrenaline and dopamine at the fronto-cortical dopaminergic and noradrenergic pathways. The combined actions of agomelatine on MT1/MT2 and 5-HT2c receptors facilitate the resynchronization of altered circadian rhythms and abnormal sleep patterns. Agomelatine appeared to be effective in treating major depression. Moreover, evidence exists that points out a possible efficacy of such drug in the treatment of bipolar depression, anxiety disorders, alcohol dependence, migraines etc. Thus, the aim of this narrative review was to elucidate current evidences on the role of agomelatine in disorders other than major depression. View Full-Text
Keywords: melatonin; melatonergic receptors; serotonin; dopamine; noradrenaline; agomelatine; anxiety; bipolar depression; seasonal affective disorder; schizophrenia; alcohol dependence; migraines; fibromyalgia; psychiatric disorders melatonin; melatonergic receptors; serotonin; dopamine; noradrenaline; agomelatine; anxiety; bipolar depression; seasonal affective disorder; schizophrenia; alcohol dependence; migraines; fibromyalgia; psychiatric disorders
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

De Berardis, D.; Fornaro, M.; Serroni, N.; Campanella, D.; Rapini, G.; Olivieri, L.; Srinivasan, V.; Iasevoli, F.; Tomasetti, C.; De Bartolomeis, A.; Valchera, A.; Perna, G.; Mazza, M.; Di Nicola, M.; Martinotti, G.; Di Giannantonio, M. Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression. Int. J. Mol. Sci. 2015, 16, 1111-1130.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top